Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in majority of patients with RET gene fusions
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted…
Browsing: RET gene fusion
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted…